Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07191457 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of Head-lice Treatments Elimax Green Lotion and Walgreens Lice Killing Shampoo
A NA study of Head Lice, sponsored by Oystershell.
- Recruiting
- Registry status
- NA
- Development phase
- 86
- Enrollment target
- 1
- Study location
NCT07191457 is a NA study of Head Lice that is actively recruiting participants, run by Oystershell. The registered enrollment target is 86 participants, below the 100-participant average among 5 other Head Lice trials with a reported enrollment target (14% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07191457, a NA study of Head Lice, is actively recruiting participants, sponsored by Oystershell.
- RECRUITING
- Registry status
- NA
- Development phase
- 86 participants
- Enrollment target
- 1
- Study location
Study Summary
Compare efficacy and safety of Elimax Green Lotion Emogreen (RID SUper Max Solution) to that of Walgreens Lice Killing Shampoo against headlice in infested individuals. Involved subjects aged 6 months and older, of both genders, with a confirmed diagnosis of head lice infestation are included. Local and global tolerability, skin and eye irritation are monitored throughout the study. Any adverse events will be monitored and recorded.
Conditions Studied
Interventions
- DEVICE Elimax Green Lotion with Emogreen
- DRUG Walgreens Lice Killing Shampoo
Study Locations (1)
Oklahoma
- LSRN Research - Enid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2025-10-02 |
| Est. Completion | 2026-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07191457
The ClinicalTrials.gov registry entry for NCT07191457 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 100-participant average among 5 other Head Lice trials with a reported enrollment target (14% lower). The listed sponsor is Oystershell, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Head Lice appearing as the primary indexed condition, and to 2 interventions - of which Elimax Green Lotion with Emogreen is the first listed.
NCT07191457 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.
Frequently Asked Questions
What is clinical trial NCT07191457 about?
NCT07191457 is a clinical study titled "Safety and Efficacy of Head-lice Treatments Elimax Green Lotion and Walgreens Lice Killing Shampoo". Compare efficacy and safety of Elimax Green Lotion Emogreen (RID SUper Max Solution) to that of Walgreens Lice Killing Shampoo against headlice in infested individuals. Involved subjects aged 6 months and older, of both genders, with a confirmed diagnosis of head lice infestation are included. Local...
What is the current status of trial NCT07191457?
This trial is currently recruiting. It is a NA study. The enrollment target is 86 participants. The study started on 2025-10-02. Estimated completion is 2026-04-01.
What conditions does trial NCT07191457 study?
This clinical trial studies the following conditions: Head Lice.
What interventions are being tested in trial NCT07191457?
The interventions under investigation include: Elimax Green Lotion with Emogreen (DEVICE), Walgreens Lice Killing Shampoo (DRUG).
Who is sponsoring clinical trial NCT07191457?
This trial is sponsored by Oystershell, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07191457 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head Lice
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Clinical Trial to Evaluate Efficacy and Safety of a Water-soluble Head Lice Product.
COMPLETED · NA
-
Safety and Efficacy Study to Compare a 4% Dimethicone Foam and Nix Cream Rinse (1% Permethrin) in the Control of Head Lice
COMPLETED · NA
-
Pediatric Head Lice Study Product Comparison
COMPLETED · Phase 2
-
Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects
COMPLETED · Phase 2
-
A Pilot Dose Ranging Study of Spinosad Creme Rinse
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.